Scoville, Elizabeth A. http://orcid.org/0000-0001-5326-2221
Allaman, Margaret M.
Brown, Caroline T.
Motley, Amy K.
Horst, Sara N.
Williams, Christopher S.
Koyama, Tatsuki
Zhao, Zhiguo
Adams, Dawn W.
Beaulieu, Dawn B.
Schwartz, David A.
Wilson, Keith T.
Coburn, Lori A.
Funding for this research was provided by:
National Institutes of Health (R01AT004821, 3R01AT004821-02S1, 2T32HD060554-06A1, 5T32DK007673, P30DK058404, UL1TR000445, P30DK020593, R01DK053620, R01CA190612, P01CA028842, P01CA116087, R01DK099204)
U.S. Department of Veterans Affairs (1IK2BX002126, I01BX001426, I01BX001453)
Article History
Received: 31 August 2017
Accepted: 21 December 2017
First Online: 29 December 2017
Compliance with ethical standards
:
: David A. Schwartz has consultancy agreements with Abbvie, UCB, Janssen, Takeda, and Tigenix. Dawn B. Beaulieu has a consultancy agreement with Abbvie. Sara N. Horst has consultancy agreements with UCB and Salix. However, these agreements and grants had no relationship to the current research study. Keith T. Wilson has had a consulting agreement with Immune Pharmaceuticals. However, this agreement had no relationship to the current research study and is no longer active. The remainder of the authors declare that they have no conflict of interest.